Why the study?
Heart failure affects millions worldwide and treatment adherence influences clinical outcomes, quality of life, and healthcare costs, prompting investigation of treatment adherence during the COVID-19 pandemic.
Satisfactory yet variable TA in HF during pandemic supports targeted support for at-risk groups; leaves open effects on outcomes.
Background and Aim: Heart failure (HF) is a common and serious condition that affects millions of people worldwide. Treatment adherence (TA) is associated with clinical outcomes, quality of life, and the cost of health services for patients with HF. This study aimed to investigate TA and its related factors in patients with HF in a selected hospital affiliated to Iran University of Medical Sciences during COVID-19 Pandemic.
No takes yet. Share an insight, caveat, or question.
Safaee et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: